Analysis of Lipids in Human Milk At Different Gestational Ages

NCT ID: NCT05989009

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

66 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-03-01

Study Completion Date

2023-10-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Various studies have shown that the milk of a preterm infant differs from that of a term infant in the composition of micronutrients, vitamins, macronutrients, carbohydrates and proteins. The study of lipidomic is of particular interest because the role of fatty acids is known both as essential constituents of cell membranes and as molecules actively involved in energy metabolism. The study of human milk would offer the advantage of offering the best type of nutrition for the newborn at each specific period of life, in the event of a lack of mother's milk.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Mother's milk is the best food for the newborn as it is the only one capable of providing species-specific nutrition, guaranteeing everything necessary for the growth and maturation of a child. Mother's milk has the property of satisfying metabolic needs by changes in the composition of nutrients, which are different at each stage of life. Various studies have shown that the milk of a preterm infant differs from that of a term infant in the composition of micronutrients, such as vitamins, macronutrients, carbohydrates and proteins. The metabolomic study of human milk would offer the advantage of offering the best type of nutrition for the newborn at each specific period of life, in the event of a lack of mother's milk. This is particularly important in a Neonatal Intensive Care Unit, where it is essential to ensure timely adequate enteral nutrition. This is possible if a bank of donated human milk is available. The study of lipidomics is of particular interest, as the role of fatty acids is known both as essential constituents of cell membranes and as molecules actively involved in energy metabolism. Therefore, the benefit deriving from an adequate dietary intake in a constantly evolving organism such as that of a newborn is extremely important.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Milk Collection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Women < 32 weeks of gestational age

Women that delivered before 32 weeks of gestational age

Breastfeeding

Intervention Type OTHER

Mothers will breastfeed their newborns

Women between 32 and 36,6 weeks of gestational age

Women that delivered between 32 and 36,6 weeks of gestational age

Breastfeeding

Intervention Type OTHER

Mothers will breastfeed their newborns

Women > 37 weeks of gestational age

Women that delivered after 37 weeks of gestational age

Breastfeeding

Intervention Type OTHER

Mothers will breastfeed their newborns

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Breastfeeding

Mothers will breastfeed their newborns

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Mothers who have given birth in hospital at any gestational age
* Written informed consent
* BMI 18.50-24.99 Kg/m2
* Varied and balanced maternal diet without restrictions
* Weight gain during pregnancy up to 12kg

Exclusion Criteria

* Food intolerance
* Celiac disease
* Vegan or vegetarian diet
* Diet with the exclusion of milk and derivatives
* Diagnosis of metabolic diseases
* Taking medicines during pregnancy
* Withdrawal of informed consent
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Salerno

OTHER

Sponsor Role collaborator

Ospedale Buon Consiglio Fatebenefratelli

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Giuseppe De Bernardo

Head of Department of Woman and Child

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Giuseppe De Bernardo, MD

Role: PRINCIPAL_INVESTIGATOR

Ospedale Buon Consiglio Fatebenefratelli

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Pharmacy, University of Salerno

Salerno, Naples, Italy

Site Status

Department of Woman and Child, Buon Consiglio Fatebenefratelli Hospital

Napoli, Napoli, Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1669/CE Lazio 1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pre/Term Milk Profiling
NCT02052245 COMPLETED
Predictors of Lactogenesis II
NCT02220413 COMPLETED